Supplementary Table S3 from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer
Year: 2024
Type: supplementary-materials
Abstract: Selected Reactome Pathways for Figure 2A
Authors: Avia D. Wilkerson, Prerana Bangalore Parthasarathy, Nickolas Stabellini, Carley Mitchell, Paul G. Pavicic, Pingfu Fu, Amit Rupani, Hana Husic, Patricia A. Rayman, Shadi Swaidani, Jame Abraham, G. Thomas Budd, Halle Moore, Zahraa Al-Hilli, Jennifer S. Ko, Joseph Baar, Timothy A. Chan, Tyler Alban, C. Marcela Diaz-Montero, Alberto J. Montero
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4390612936